Baird Medical Investment ... (BDMD)
Baird Medical Investment Statistics
Share Statistics
Baird Medical Investment has 35.45M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 35.45M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 10.84K |
| FTD / Avg. Volume | 13.44% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 7.7 and the forward PE ratio is null. Baird Medical Investment's PEG ratio is -0.01.
| PE Ratio | 7.7 |
| Forward PE | n/a |
| PS Ratio | 2.58 |
| Forward PS | n/a |
| PB Ratio | 2.27 |
| P/FCF Ratio | -22.2 |
| PEG Ratio | -0.01 |
Enterprise Valuation
Baird Medical Investment has an Enterprise Value (EV) of 91.22M.
| EV / Sales | 2.9 |
| EV / EBITDA | 7.1 |
| EV / EBIT | -89.44 |
| EV / FCF | -24.94 |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 0.32.
| Current Ratio | 2.11 |
| Quick Ratio | 2.05 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 0.9 |
| Debt / FCF | -3.15 |
| Interest Coverage | 41.5 |
Financial Efficiency
Return on Equity is 29.5% and Return on Invested Capital is 21.66%.
| Return on Equity | 29.5% |
| Return on Assets | 18.6% |
| Return on Invested Capital | 21.66% |
| Revenue Per Employee | $212.55K |
| Profits Per Employee | $71.26K |
| Employee Count | 148 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 3.7 |
Taxes
| Income Tax | 1.7M |
| Effective Tax Rate | 13.76% |
Stock Price Statistics
The stock price has increased by -50.09% in the last 52 weeks. The beta is -0.73, so Baird Medical Investment's price volatility has been lower than the market average.
| Beta | -0.73 |
| 52-Week Price Change | -50.09% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 6.32 |
| Relative Strength Index (RSI) | 48.76 |
| Average Volume (20 Days) | 80.65K |
Income Statement
In the last 12 months, Baird Medical Investment had revenue of 31.46M and earned 10.55M in profits. Earnings per share was -0.22.
| Revenue | 31.46M |
| Gross Profit | 27.23M |
| Operating Income | 11.86M |
| Net Income | 10.55M |
| EBITDA | 12.85M |
| EBIT | 11.86M |
| Earnings Per Share (EPS) | -0.22 |
Balance Sheet
The company has 1.51M in cash and 11.51M in debt, giving a net cash position of -10M.
| Cash & Cash Equivalents | 1.51M |
| Total Debt | 11.51M |
| Net Cash | -10M |
| Retained Earnings | 14.39M |
| Total Assets | 63M |
| Working Capital | 24.58M |
Cash Flow
In the last 12 months, operating cash flow was -1.02M and capital expenditures -2.64M, giving a free cash flow of -3.66M.
| Operating Cash Flow | -1.02M |
| Capital Expenditures | -2.64M |
| Free Cash Flow | -3.66M |
| FCF Per Share | -0.48 |
Margins
Gross margin is 86.56%, with operating and profit margins of 37.71% and 33.52%.
| Gross Margin | 86.56% |
| Operating Margin | 37.71% |
| Pretax Margin | 39.29% |
| Profit Margin | 33.52% |
| EBITDA Margin | 40.86% |
| EBIT Margin | 37.71% |
| FCF Margin | -11.63% |
Dividends & Yields
BDMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 12.98% |
| FCF Yield | -4.5% |
Analyst Forecast
Currently there are no analyst rating for BDMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 6.62 |
| Piotroski F-Score | 5 |